EVERZOM

everzom-logo

EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles. They develop a bioproduction platform to produce extracellular vesicles at a commercial scale in a GMP compliant way for pharmaceutical companies with applications in regenerative medicine and drug delivery. Extracellular vesicles that encompass exosomes, microvesicles, and apoptotic bodies are the tools used by cells to communicate with each other. EVerZom was founded in 2019 and is headquartered in Paris, Ile-de-France, France.

#People #Financial #Website #More

EVERZOM

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1919-07-01

Address:
Paris, Ile-de-France, France

Country:
France

Website Url:
http://www.everzom.com

Total Employee:
1+

Status:
Active

Contact:
+33678280120

Email Addresses:
nicolas.rousseau@everzom.com

Total Funding:
2.87 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Current Employees Featured

jeanne-volatron_image

Jeanne Volatron
Jeanne Volatron CEO and Co-founder @ EVerZom
CEO and Co-founder

Founder


jeanne-volatron_image

Jeanne Volatron

Investors List

european-innovation-council_image

European Innovation Council

European Innovation Council investment in Grant - EVerZom

Official Site Inspections

http://www.everzom.com Semrush global rank: 10.35 M Semrush visits lastest month: 2

  • Host name: 152.228.168.93
  • IP address: 152.228.168.93
  • Location: Valparaiso United States
  • Latitude: 41.4549
  • Longitude: -87.0613
  • Metro Code: 602
  • Timezone: America/Chicago
  • Postal: 46383

Loading ...

More informations about "EVerZom"

EVerZom - Exosome biotech company

EVerZom is an exosome biotech company developing exosome therapeutics in digestive tissue healing, fistula and organ regeneration.See details»

EVerZom - Crunchbase Company Profile & Funding

EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.See details»

Everzom SAS - Drug pipelines, Patents, Clinical trials - Synapse

EVERZOM is a Contract Development and Manufacturing Organization (CDMO) specialized in exosomes, which spun out from the CNRS Laboratory at the University of Paris Cité in 2019.See details»

Discover the EverZom team

At EVerZom, we have successfully overcome the challenge of high-yield, large-scale and cost-effective exosome production and developed a unique proprietary innovation platform.See details»

EVerZom Company Profile - Office Locations, Competitors ... - Craft

EVerZom has 5 employees at their 1 location and $1.32 m in total funding,. See insights on EVerZom including office locations, competitors, revenue, financials, executives, subsidiaries …See details»

EVerZom 2025 Company Profile: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for EVerZom. Use the PitchBook Platform to explore the full profile.See details»

EVerZom Locations - Contract Research Map

Information about my organization is incorrect, how do I fix it? Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two …See details»

Our history - Everzom

In September 2018, EVerZom integrated Deeptech Founders Training, a unique program for entrepreneurial scientists and engineers to accelerate their startup projects. We were trained …See details»

EverZom - VentureRadar

"EverZom develops a bioproduction platform to manufacture exosomes at clinical grade and large scale based on a unique proprietary technolgy. We provide custom bioprocess development, …See details»

EVerZom - Funding, Financials, Valuation & Investors

EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.See details»

EVERZOM Company Profile | PARIS, ILE DE FRANCE, France

Find company research, competitor information, contact details & financial data for EVERZOM of PARIS, ILE DE FRANCE. Get the latest business insights from Dun & Bradstreet.See details»

EVerZom - Crunchbase

EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.See details»

EVerZom - Org Chart, Teams, Culture & Jobs | The Org

View EVerZom's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

EVerZom Board - Everzom

Clinical board Gabriel Rahmi Board President & shareholder Gastroenterologist HEGP Hospital Interventional endoscopy Antoine Monsel Board member ICU doctor specialized in hepatology …See details»

Erganeo signs a licensing agreement with start-up EverZom, …

Dec 9, 2019 On Tuesday, 3 December, Erganeo and start-up EVerZom signed an exclusive licensing agreement for the development of an innovative extracellular vesicle bioproduction …See details»

Everzom - healthtechinnovationdays6.com

Sep 17, 2024 We develop a therapeutic platform based on stem cell exosomes from adipose tissue with strong immunomodulatory and regenerative properties. We target 3 main …See details»

EVerZom achieves first bioproduction of clinical grade stem

Oct 2, 2024 EVerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors in partnership with the French Blood Establishment (EFS) with …See details»

EVerZom achieves first bioproduction of clinical grade stem cell ...

Dec 16, 2024 The disruptive, proprietary technology developed by EVerZom offers a yield 100 times higher than traditional methods. This innovation has just been tech-transferred and …See details»

Innovation platform - Everzom

EVerZom platform is built on four blocks from the cell source to the formulated exosome drugSee details»

EVerZom achieves first bioproduction of clinical grade stem cell ...

Oct 2, 2024 EVerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors in partnership with the French Blood Establishment (EFS) with …See details»

linkstock.net © 2022. All rights reserved